Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


2nd Annual World Orphan Drug Congress 2012

17 Oct 2012 - 18 Oct 2012 - Barcelona, Spain



Bookmark and Share


In order to discuss major concerns, the newest solutions and challenges connected with prevention, diagnosis and treatment of rare diseases, Fleming Europe has organized its 2nd Annual Orphan Drug Congress 2012. On 17 – 18 October 2012 the top-level pharmaceutical experts in orphan drug development, regulatory affairs & pricing will gather in Barcelona to discuss this year's critical issues.

Focused interactive discussions integrated between individual presentation blocks will provide enough space and a unique opportunity to exchange ideas with industry peers and get the answers from our speakers.

The attendees will have the opportunity to:

  • Understand the infrastructure in order to gain approval in emerging markets 
  • Gain critical insights behind the successful development, authorization and  reimbursement of rare disease drugs 
  • Find out how to regulate the use of social media for orphan drugs & rare diseases 
  • Explore the importance of communication Between Pharma, Patient & HTA Bodies 
  • Meet the top executives and experts from leading pharmaceutical companies as well as  from medium and small pharma companies with the focus on rare and neglected    diseases

For further details please request the event brochure http://pharma.flemingeurope.com/orphan-drug-congress/request-agenda




Further information
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!